637 related articles for article (PubMed ID: 33684560)
1. Main differences between the first and second waves of COVID-19 in Madrid, Spain.
Soriano V; Ganado-Pinilla P; Sanchez-Santos M; Gómez-Gallego F; Barreiro P; de Mendoza C; Corral O
Int J Infect Dis; 2021 Apr; 105():374-376. PubMed ID: 33684560
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.
Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I
PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363
[TBL] [Abstract][Full Text] [Related]
3. Could masks curtail the post-lockdown resurgence of COVID-19 in the US?
Ngonghala CN; Iboi EA; Gumel AB
Math Biosci; 2020 Nov; 329():108452. PubMed ID: 32818515
[TBL] [Abstract][Full Text] [Related]
4. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
[TBL] [Abstract][Full Text] [Related]
5. National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic.
Palmateer NE; Dickson E; Furrie E; Godber I; Goldberg DJ; Gousias P; Jarvis L; Mathie L; Mavin S; McMenamin J; McNeilly TN; Murcia P; Murray J; Reid G; Robertson C; Templeton K; von Wissmann B; Wallace LA; Waugh C; McAuley A
Public Health; 2021 Sep; 198():102-105. PubMed ID: 34411992
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain.
Videla S; Otero A; Martí S; Domínguez MÁ; Fabrellas N; Delgado-Hito MP; Cruz I; Tebé C; Vinuesa T; Ardila F; Sancho M; Fernández E; Figuerola M; Ciruela F
Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34204383
[TBL] [Abstract][Full Text] [Related]
7. The university as a safe environment during the SARS-COV-2 pandemic: the experience of Bari Politecnico.
Cupertino F; Spataro S; Spinelli G; Schirinzi A; Bianchi FP; Stefanizzi P; Di Serio F; Tafuri S
Ann Ig; 2021; 33(2):201-202. PubMed ID: 33570091
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures.
Leuzinger K; Gosert R; Søgaard KK; Naegele K; Bielicki J; Roloff T; Bingisser R; Nickel CH; Khanna N; Sutter ST; Widmer AF; Rentsch K; Pargger H; Siegemund M; Stolz D; Tamm M; Bassetti S; Osthoff M; Battegay M; Egli A; Hirsch HH
J Med Virol; 2021 Apr; 93(4):2374-2384. PubMed ID: 33314153
[TBL] [Abstract][Full Text] [Related]
9. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
10. Mathematical modeling of the transmission of SARS-CoV-2-Evaluating the impact of isolation in São Paulo State (Brazil) and lockdown in Spain associated with protective measures on the epidemic of CoViD-19.
Yang HM; Lombardi Junior LP; Castro FFM; Yang AC
PLoS One; 2021; 16(6):e0252271. PubMed ID: 34129608
[TBL] [Abstract][Full Text] [Related]
11. Should face masks be worn to contain the spread of COVID-19 in the postlockdown phase?
Landi F; Marzetti E; Sanguinetti M; Ciciarello F; Tritto M; Benvenuto F; Bramato G; Brandi V; Carfì A; D'Angelo E; Fusco D; Lo Monaco MR; Martone AM; Pagano F; Rocchi S; Rota E; Russo A; Salerno A; Cattani P; Marchetti S; Bernabei On Behalf Of The Gemelli Against Covid-Geriatric Team R
Trans R Soc Trop Med Hyg; 2021 Jan; 115(1):74-77. PubMed ID: 32948871
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
[TBL] [Abstract][Full Text] [Related]
13. Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings.
Candel FJ; Barreiro P; San Román J; Abanades JC; Barba R; Barberán J; Bibiano C; Canora J; Cantón R; Calvo C; Carretero M; Cava F; Delgado R; García-Rodríguez J; González Del Castillo J; González de Villaumbrosia C; Hernández M; Losa JE; Martínez-Peromingo FJ; Molero JM; Muñoz P; Onecha E; Onoda M; Rodríguez J; Sánchez-Celaya M; Serra JA; Zapatero A
Rev Esp Quimioter; 2020 Dec; 33(6):466-484. PubMed ID: 33070578
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 seroprevalence in blood donors before and after the first wave in Catalonia (Spain).
Piron M; Jané M; Ciruela P; Basile L; Martínez A; Puig L; Bes M; Sauleda S
Blood Transfus; 2022 Sep; 20(5):353-361. PubMed ID: 35175189
[TBL] [Abstract][Full Text] [Related]
15. The Second Wave of SARS-CoV-2 Circulation-Antibody Detection in the Domestic Cat Population in Germany.
Michelitsch A; Schön J; Hoffmann D; Beer M; Wernike K
Viruses; 2021 May; 13(6):. PubMed ID: 34072254
[TBL] [Abstract][Full Text] [Related]
16. Third wave of COVID-19 in Madrid, Spain.
Soriano V; de Mendoza C; Gómez-Gallego F; Corral O; Barreiro P
Int J Infect Dis; 2021 Jun; 107():212-214. PubMed ID: 33930544
[TBL] [Abstract][Full Text] [Related]
17. First Wave of COVID-19 Pandemic in Italy: Data and Evidence.
Bezzini D; Schiavetti I; Manacorda T; Franzone G; Battaglia MA
Adv Exp Med Biol; 2021; 1353():91-113. PubMed ID: 35137370
[TBL] [Abstract][Full Text] [Related]
18. Altitude and SARS-CoV-2 Infection in the First Pandemic Wave in Spain.
Castilla J; Fresán U; Trobajo-Sanmartín C; Guevara M
Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33806642
[TBL] [Abstract][Full Text] [Related]
19. The seroprevalence of SARS-CoV-2 in a rural southwest community.
Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
